Concord Biotech shares list at 21% premium; surge up to 26% post debut
Post listing, Concord Biotech shares gained 26.2% to hit a high of ₹934.90 on the BSE, while it touched a high of ₹925.90 on the NSE, up 25% against the IPO price.
biotechnology
August 2023
June 2021
May 2021
April 2020
How technology is helping India to fight Covid-19
At the heart of the crisis-led watershed moment is an unprecedented scale of digital adoption across government agencies, industries, medical bodies, and enterprises.
The Ellas of Bharat Biotech: The gift of the jab
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
Mylab: The startup in the limelight
The Pune-based company is pioneering the production of test kits to screen for Covid-19. With fresh funding, it hopes to rapidly ramp up capacity.
